HomeOwner SearchCategory Search
Visit USCOChimeric Antigen Receptor Macrophage Driving Interleukin-4 / Interleukin-13 Based Anti-inflammatory Response
Text Registration
Copyright Title
Chimeric Antigen Receptor Macrophage Driving Interleukin-4 / Interleukin-13 Based Anti-inflammatory Response
Status
Published
on 5 May 2020
Year of Creation
2020
Copyright Claimant
Adam Cotty
Registration Number
TX0008872044
on 5 May 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008872044) dated 5 May 2020, pertains to an electronic file (eService) titled "Chimeric Antigen Receptor Macrophage Driving Interleukin-4 / Interleukin-13 Based Anti-inflammatory Response" created in 2020. The copyright holder is Adam Cotty, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Adam Cotty.
Application Details
Registration Number
TX0008872044
Registration Date
5/5/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Chimeric Antigen Receptor Macrophage Driving Interleukin-4 / Interleukin-13 Based Anti-inflammatory Response
Author Statement: Adam R. Cotty Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.